Carisma Therapeutics
Delivering macrophage biology, chimeric antigen receptor engineering and adoptive cellular therapy for the treatment of human disease.
HQ location
Philadelphia, United States
Website
Launch date
Employees
Market cap
$17.4m
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| investor | €0.0 | round | |
| investor investor investor | €0.0 | round | |
| investor investor investor | €0.0 | round | |
| investor investor investor | €0.0 | round | |
| investor investor investor investor investor investor investor investor | €0.0 | round | |
| investor investor investor | €0.0 Valuation: €0.0 | round | |
| investor investor investor investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
* | N/A | N/A | Acquisition |
| Total Funding | 000k | ||
Abbvie Biotech Ventures(exited)
HealthCap(exited)
Agent Capital(exited)
IP Group(exited)
Livzon Pharmaceutical Group(exited)
Solasta Ventures(exited)
TPG Biotech(exited)
Wellington Partners(exited)
4BIO Capital(exited)
Penn Medicine(exited)
MRL Ventures(exited)
AbbVie(exited)
Pictet(exited)
University of Pennsylvania(exited)
Penn Center for Innovation(exited)
| USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | - | - | 52 % | 32 % | (24 %) |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | - | - | (552 %) | (575 %) | (300 %) | - |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | - | - | (623 %) | (582 %) | (308 %) | - |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | - | - | 576 % | 497 % | 304 % | - |
Source: Company filings or news article, Equity research estimates
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Carisma Therapeutics
Edit
ACQUISITION by Carisma Therapeutics Sep 2022